Home > News > Targeting Nanoparticles to Leukemia Cells and T-Lymphocytes
June 1st, 2005
Targeting Nanoparticles to Leukemia Cells and T-Lymphocytes
Abstract:
Investigators in Germany have developed a method for creating antibody-labeled gelatin nanoparticles that can target specific cells and then dissolve upon uptake by those cells, raising the possibility that gelatin nanoparticles could serve as biodegradable drug delivery vehicles. Reporting its work in the journal Biomaterials, a research team led by Hagen von Briesen, Ph.D., of the Fraunhofer Institute for Biomedical Engineering in St. Ingbert, Germany, showed that crosslinked gelatin nanoparticles could be readily labeled with an antibody that binds to the cell-surface protein CD3. This protein is found on the surface of certain types of leukemic T-lymphocytes.
Source:
NCI
Bookmark:
| Related Links |
Fraunhofer Institute for Biomedical Engineering
| Related News Press |
Possible Futures
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||